|
1
|
VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.
|
Cancer Res
|
2002
|
3.19
|
|
2
|
VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression.
|
Cancer Res
|
2004
|
3.03
|
|
3
|
A new postoperative predictor of time to urinary continence after laparoscopic radical prostatectomy: the urine loss ratio.
|
Eur Urol
|
2006
|
2.22
|
|
4
|
Ureteral reimplantation for management of ureteral strictures: a retrospective comparison of laparoscopic and open techniques.
|
Eur Urol
|
2006
|
1.41
|
|
5
|
Minimally invasive treatment of ureteropelvic junction obstruction: long-term experience with an algorithm for laser endopyelotomy and laparoscopic retroperitoneal pyeloplasty.
|
J Urol
|
2007
|
0.97
|
|
6
|
PTEN-mediated pathways and their association with treatment-resistant prostate cancer.
|
BJU Int
|
2009
|
0.89
|
|
7
|
Prognostic factors for upper tract transitional cell carcinoma: a retrospective review of 66 patients.
|
Asian J Surg
|
2008
|
0.79
|
|
8
|
Differential expression of vascular endothelial growth factor165b in transitional cell carcinoma of the bladder.
|
Urol Oncol
|
2007
|
0.79
|
|
9
|
Survival of patients with transitional cell carcinoma of the urinary bladder in indonesia: a single institution review.
|
Asian Pac J Cancer Prev
|
2011
|
0.79
|
|
10
|
Testosterone replacement therapy in prostate cancer patients: is it safe?
|
Acta Med Indones
|
2010
|
0.75
|